Daiichi Sankyo reported JPY97.98B in Cost of Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Astellas Pharma 4503:JP JPY 74.42B 11.64B
Chugai Pharma 4519:JP JPY 212.91B 143.81B
Daiichi Sankyo 4568:JP JPY 97.98B 13.21B
Eisai 4523:JP JPY 46.74B 1.6B
Kyowa Hakko Kirin 4151:JP JPY 22.77B 2B
M3 2413:JP JPY 24.82B 1.11B
Otsuka Holdings 4578:JP JPY 142.49B 10.24B
Shionogi 4507:JP JPY 17.2B 2.78B
Sumitomo Dainippon 4506:JP JPY 46.92B 140M
Takeda 4502:JP JPY 335.97B 30.53B
Terumo 4543:JP JPY 103.32B 2.7B